Active ingredient
Fexofenadine HCl USP 60 mg (for 60 mg)
Fexofenadine HCl USP 180 mg (for 180 mg)
Uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose
- sneezing
- itchy, watery eyes
- itching of the nose or throat
Warnings
Do not use
if you have ever had an allergic reaction to this product or any of its ingredients.
Ask a doctor before use if you have
kidney disease. Your doctor should determine if you need a different dose.
When using this product
- do not take more than directed
- do not take at the same time as aluminum or magnesium antacids
- do not take with fruit juices (see Directions)
Stop use and ask a doctor if
an allergic reaction to this product occurs. Seek medical help right away.
If pregnant or breast-feeding
ask a health professional before use.
Keep out of reach of children
In case of overdose, get medical help or contact a Poison Control Center right away
Directions
adults and children 12 years of age and over |
take one 60 mg tablet with water every 12 hours; do not take more than 2 tablets in 24 hours (for 60 mg)
take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours (for 180 mg)
|
children under 12 years of age
|
do not use
|
adults 65 years of age and older
|
ask a doctor
|
consumers with kidney disease
|
ask a doctor
|
Other information
- Safety-sealed: do not use if imprinted foil under bottle cap is opened or torn.
- store between 20º and 25ºC (68º and 77ºF)
- protect from excessive moisture
Inactive ingredients
colloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide black, iron oxide red, iron oxide yellow, lactose monohydrate, macrogol, magnesium stearate, microcrystalline cellulose, pregelatinized starch, titanium dioxide.
Questions?
call 1-877-770-3183: Mon-Fri 8:00 AM EST to 5:00 PM PST.
C'rcle Allergy Relief
Fexofenadine HCl Tablets, USP 60 mg
Antihistamine
100 Tablets

NDC 57483-240-02
C'rcle Allergy Relief
Fexofenadine HCl Tablets, USP 180 mg
Antihistamine
150 Tablets

Innovus Pharmaceuticals, Inc.